Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRICHLORMETHIAZIDE Cause Hepatic function abnormal? 6 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hepatic function abnormal have been filed in association with TRICHLORMETHIAZIDE. This represents 1.8% of all adverse event reports for TRICHLORMETHIAZIDE.

6
Reports of Hepatic function abnormal with TRICHLORMETHIAZIDE
1.8%
of all TRICHLORMETHIAZIDE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Hepatic function abnormal From TRICHLORMETHIAZIDE?

Of the 6 reports, 3 (50.0%) required hospitalization.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRICHLORMETHIAZIDE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does TRICHLORMETHIAZIDE Cause?

Dyspnoea (105) Cough (104) Drug ineffective (103) Obstructive airways disorder (103) Pneumonia (101) Bronchial secretion retention (97) Eosinophil count increased (97) Multiple allergies (97) Pulmonary mass (97) Sputum culture positive (97)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which TRICHLORMETHIAZIDE Alternatives Have Lower Hepatic function abnormal Risk?

TRICHLORMETHIAZIDE vs TRICLOSAN TRICHLORMETHIAZIDE vs TRIENTINE TRICHLORMETHIAZIDE vs TRIENTINE TETRAHYDROCHLORIDE TRICHLORMETHIAZIDE vs TRIFAROTENE TRICHLORMETHIAZIDE vs TRIFLUOPERAZINE

Related Pages

TRICHLORMETHIAZIDE Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal TRICHLORMETHIAZIDE Demographics